Evidence map›Paper›PMID 24451377›Full record

ArticleThe Journal of biological chemistry2014

The Chinese herb isolate yuanhuacine (YHL-14) induces G2/M arrest in human cancer cells by up-regulating p21 protein expression through an p53 protein-independent cascade.

Ruowen Zhang, Yulei Wang, Jingxia Li, Honglei Jin, Shaojiang Song, Chuanshu Huang

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Daphnane-type diterpenes from genusChinese herbal medicines · 2021
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Wound Healing and the Use of Medicinal Plants.Evidence-based complementary and alternative medicine : eCAM · 2019
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Ruowen ZhangNelson Institute of Environmental Medicine, New York University School of Medicine, Tuxedo, New York 10987; Key Laboratory of Structure-based Drug Design and Discovery, School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, China.
Yulei WangNelson Institute of Environmental Medicine, New York University School of Medicine, Tuxedo, New York 10987.
Jingxia LiNelson Institute of Environmental Medicine, New York University School of Medicine, Tuxedo, New York 10987.
Honglei JinNelson Institute of Environmental Medicine, New York University School of Medicine, Tuxedo, New York 10987.
Shaojiang SongKey Laboratory of Structure-based Drug Design and Discovery, School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, China. Electronic address: songsj99@gmail.com.
Chuanshu HuangNelson Institute of Environmental Medicine, New York University School of Medicine, Tuxedo, New York 10987. Electronic address: chuanshu.huang@nyumc.org.
New York University · USShenyang Pharmaceutical University · CN

Funding

Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ANIRBAN MAITRA · 1985 to 2026
$83.1M
Reagent/Service CoreP01CA165980 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI TANG, ERIC MOON-SHONG M. · 2013 to 2023
$13.5M
Molecular Mechanisms of Nickel-Induced TumorigenicityR01CA112557 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI HUANG, CHUANSHU · 2004 to 2016
$2.9M
Mechanisms underlying therapeutic effect of a new compound Isorhapontigenin (ISO)R01CA177665 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI HUANG, CHUANSHU · 2013 to 2018
$1.7M
NCI NIH HHS P01 CA165980NCI NIH HHS P30 CA016087NCI NIH HHS R01 CA112557NCI NIH HHS R01 CA177665
6 · The paper itself

Abstract

Yuanhuacine (YHL-14), the major component of daphnane diterpene ester isolated from the flower buds of Daphne genkwa, has been reported to have activity against cell proliferation in various cancer cell lines. Nevertheless, the potential mechanism has not been explored yet. Here we demonstrate that YHL-14 inhibits bladder and colon cancer cell growth through up-regulation of p21 expression in an Sp1-dependent manner. We found that YHL-14 treatment resulted in up-regulation of p21 expression and a significant G2/M phase arrest in T24T and HCT116 cells without affecting p53 protein expression and activation. Further studies indicate that p21 induction by YHL-14 occurs at the transcriptional level via up-regulation of Sp1 protein expression. Moreover, our results show that p38 is essential for YHL-14-mediated Sp1 protein stabilization, G2/M growth arrest induction, and anchorage-independent growth inhibition of cancer cells. Taken together, our studies demonstrate a novel mechanism of YHL-14 against cancer cell growth in bladder and colon cancer cell lines, which provides valuable information for the design and synthesis of other new conformation-constrained derivatives on the basis of the structure of YHL-14 for cancer therapy.

Indexed as

Antineoplastic AgentsCell Line, TumorColonic NeoplasmsCyclin-Dependent Kinase Inhibitor p21DaphneDiterpenesDrugs, Chinese HerbalG2 Phase Cell Cycle CheckpointsHumansTumor Suppressor Protein p53Up-RegulationUrinary Bladder NeoplasmsAntineoplastic AgentsCyclin-Dependent Kinase Inhibitor p21DiterpenesDrugs, Chinese HerbalTumor Suppressor Protein p53YuanhuacinAnticancer DrugCell GrowthMAPKp21p38Protein StabilitySp1Yuanhuacine

Identifiers

PMID24451377
PMCPMC3945306
OpenAlexW2001663395

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.